RE:RE:Random Thoughts
Right now company is exactly in the same position as January 2018 with BLA on the table and most imp no debt and Cash in Hand. Very sound balance sheet. In Jan 2018, we were at over 1 billion valuation. If by any chance ,the company manages to submit BLA on time and this time BLA has covered all fda issues , so possibility of approval is almost 100%. This will be 2-3Billion company in a weeks time and xan potentially be 10-15 bagger. Market is just not confident considering last 2 years of mess